NCT02775448 is a Phase 2 clinical trial of Carduus marianus 6cH in Dyslipidemia, sponsored by Hospital Nacional Homeopático, Mexico.

Who is sponsoring NCT02775448?

NCT02775448 is sponsored by Hospital Nacional Homeopático, Mexico.

What drugs are being tested in NCT02775448?

Interventions in NCT02775448: Carduus marianus 6cH, Carduus marianus 12cH, Carduus marianus 30cH, Placebo, Exercise, Diet.

What condition does NCT02775448 study?

NCT02775448 studies Dyslipidemia, Menopause, Obesity.

Is NCT02775448 still recruiting?

NCT02775448 is currently terminated. Last updated 26 February 2019.

Last reviewed 2019-02-26 · How we verify

NCT02775448

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Dose-response Study of the Efficacy and Safety of Carduus Marianus in Centesimal Scale for Dyslipidemia in Overweighed or Obese Women in Peri- and Postmenopause: a Randomized Controlled Trial

Terminated Phase 2 Last updated 26 February 2019

What this trial tests

Phase 2 trial testing Carduus marianus 6cH in Dyslipidemia in 62 participants. Terminated before completion.

Timeline

1 February 2016

Primary endpoint
1 August 2017

1 September 2017

Quick facts

Lead sponsor	Hospital Nacional Homeopático, Mexico
Phase	Phase 2
Status	Terminated
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	quadruple
Primary purpose	treatment
Enrollment	62
Start date	1 February 2016
Primary completion	1 August 2017
Estimated completion	1 September 2017
Sites	1 location across Mexico

Drugs / interventions tested

Carduus marianus 6cH — full drug profile →
Carduus marianus 12cH — full drug profile →
Carduus marianus 30cH — full drug profile →
Placebo
Exercise
Diet

Conditions studied

Dyslipidemia — all drugs for Dyslipidemia →
Menopause — all drugs for Menopause →
Obesity — all drugs for Obesity →

Sponsor

Hospital Nacional Homeopático, Mexico

Who can join

Adults 40 to 65, female only, with Dyslipidemia or Menopause. Patients with the condition only — healthy volunteers not accepted.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Change from baseline level of triglycerides at 4 and 8 weeks.
Time frame: 4 and 8 weeks after randomization
Change from baseline level of total cholesterol at 4 and 8 weeks.
Time frame: 4 and 8 weeks after randomization

Sponsor's own description

Metabolic disorders including hypercholesterolemia and hypertriglyceridemia are present in climacteric women. Carduus marianus is a homeopathic medicine that traditionally has been used for hepatic diseases. It has been used for reducing hypercholesterolemia and hypertriglyceridemia also. The aim of this study is to investigate the most effective dose of Carduus marianus in centesimal scale (6cH, 12cH, 30cH, placebo) plus diet and exercise for reducing hypertriglyceridemia and/or hypercholesterolemia in climacteric women.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Dyslipidemia

Currently open trials in the same condition.

NCT07238556 — A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors · NA · recruiting
NCT07268781 — Impact of Golden Rice-Piper Crocatum Cookies on Lipid Control in Diabetes Mellitus Patients · NA · active not recruiting
NCT06919302 — The Effect of a Digital Heart Health App and Lifestyle Intervention for Heart Disease in Primary Care. · NA · recruiting
NCT07162441 — A Two-arm, Open-label, Single-sequence, Multiple-dose, Cross-over Study to Evaluate the Pharmacokinetic Interaction and · Phase 1 · recruiting
NCT07043166 — Cardiovascular-Kidney-Metabolic Syndrome in Shanghai Zicitizens · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02775448 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hospital Nacional Homeopático, Mexico
Last refreshed: 26 February 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02775448.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing